BRPI0719345A2 - Di-hidroimidazóis substituídos e seu uso no tratamento de tumores. - Google Patents
Di-hidroimidazóis substituídos e seu uso no tratamento de tumores.Info
- Publication number
- BRPI0719345A2 BRPI0719345A2 BRPI0719345-9A2A BRPI0719345A BRPI0719345A2 BR PI0719345 A2 BRPI0719345 A2 BR PI0719345A2 BR PI0719345 A BRPI0719345 A BR PI0719345A BR PI0719345 A2 BRPI0719345 A2 BR PI0719345A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- hydroimidazols
- replaced
- treatment treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/40—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06124802 | 2006-11-27 | ||
| PCT/EP2007/062804 WO2008065068A2 (en) | 2006-11-27 | 2007-11-26 | Substituted dihydroimidazoles and their use in the treatment of tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0719345A2 true BRPI0719345A2 (pt) | 2014-03-18 |
Family
ID=38288488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0719345-9A2A BRPI0719345A2 (pt) | 2006-11-27 | 2007-11-26 | Di-hidroimidazóis substituídos e seu uso no tratamento de tumores. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100075966A1 (pt) |
| EP (1) | EP2097386A2 (pt) |
| JP (1) | JP2010510974A (pt) |
| KR (1) | KR20090083408A (pt) |
| CN (1) | CN101541759A (pt) |
| AU (1) | AU2007327621A1 (pt) |
| BR (1) | BRPI0719345A2 (pt) |
| CA (1) | CA2670105A1 (pt) |
| MX (1) | MX2009005622A (pt) |
| WO (1) | WO2008065068A2 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2404919E (pt) | 2005-11-08 | 2013-10-22 | Vertex Pharma | Composto heterocíclico útil como um modulador de transportadores de cassete de ligação a atp |
| EP2164840A2 (en) | 2007-05-09 | 2010-03-24 | Vertex Pharmaceuticals Incorporated | Modulators of cftr |
| HUE049642T2 (hu) | 2007-12-07 | 2020-09-28 | Vertex Pharma | 3-(6-(1-(2,2-Difluorbenzo[d][1,3]dioxol-5-il)-ciklopropánkarboxamido)-3-metilpiridin-2-il)-benzoesav szilárd formái |
| CA2989620C (en) | 2007-12-07 | 2022-05-03 | Vertex Pharmaceuticals Incorporated | Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
| CA2716109C (en) | 2008-02-28 | 2016-07-19 | Vertex Pharmaceuticals Incorporated | Heteroaryl derivatives as cftr modulators |
| NZ616097A (en) * | 2008-03-31 | 2015-04-24 | Vertex Pharma | Pyridyl derivatives as cftr modulators |
| WO2010006792A1 (de) * | 2008-07-16 | 2010-01-21 | Bitop Ag | Synthese von zyklischen amidinen |
| ES2900353T3 (es) | 2010-04-07 | 2022-03-16 | Vertex Pharma | Composiciones farmacéuticas de ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiriidin-2-il)benzoico y administración de las mismas |
| WO2012045018A1 (en) | 2010-09-30 | 2012-04-05 | St. Jude Children's Research Hospital | Aryl-substituted imidazoles |
| NZ727015A (en) | 2012-01-25 | 2017-12-22 | Vertex Pharma | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| WO2014100065A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
| CA2930199C (en) | 2013-11-12 | 2022-10-25 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases |
| HUE055423T2 (hu) | 2014-11-18 | 2021-11-29 | Vertex Pharma | Eljárás nagy áteresztõképességû tesztelõ nagy teljesítményû folyadék-kromatográfia elvégzésére |
| EP3242875B1 (en) * | 2015-01-09 | 2022-02-23 | Genentech, Inc. | 4,5-dihydroimidazole derivatives and their use as histone demethylase (kdm2b) inhibitors |
| SG11201911909UA (en) * | 2017-06-16 | 2020-01-30 | Unity Biotechnology Inc | Synthesis method for producing enantiomerically pure cis-imidazoline compounds for pharmaceutical use |
| US20220380317A1 (en) * | 2019-06-27 | 2022-12-01 | Nanyang Technological University | Compounds having antimalarial activity |
| PH12022551379A1 (en) | 2019-12-06 | 2023-05-03 | Vertex Pharma | Substituted tetrahydrofurans as modulators of sodium channels |
| KR102622992B1 (ko) * | 2021-03-29 | 2024-01-10 | 주식회사 퓨전바이오텍 | 이미다졸린 유도체 및 이의 중간체 제조방법 |
| SI4347031T1 (sl) | 2021-06-04 | 2026-01-30 | Vertex Pharmaceuticals Incorporated | N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov |
| US11976047B1 (en) * | 2023-11-07 | 2024-05-07 | King Faisal University | 4,5-bis(4-bromo-phenyl)-1-hexyl-2-(2- methoxyphenyl)-1H-imidazole as an antimicrobial compound |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080027969A (ko) * | 2004-05-18 | 2008-03-28 | 에프. 호프만-라 로슈 아게 | 신규 ｃｉｓ-이미다졸린 |
-
2007
- 2007-11-26 EP EP07822860A patent/EP2097386A2/en not_active Withdrawn
- 2007-11-26 CA CA002670105A patent/CA2670105A1/en not_active Abandoned
- 2007-11-26 MX MX2009005622A patent/MX2009005622A/es not_active Application Discontinuation
- 2007-11-26 CN CNA2007800437651A patent/CN101541759A/zh active Pending
- 2007-11-26 KR KR1020097010729A patent/KR20090083408A/ko not_active Withdrawn
- 2007-11-26 JP JP2009537654A patent/JP2010510974A/ja active Pending
- 2007-11-26 BR BRPI0719345-9A2A patent/BRPI0719345A2/pt not_active Application Discontinuation
- 2007-11-26 WO PCT/EP2007/062804 patent/WO2008065068A2/en not_active Ceased
- 2007-11-26 AU AU2007327621A patent/AU2007327621A1/en not_active Abandoned
- 2007-11-26 US US12/516,414 patent/US20100075966A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008065068A3 (en) | 2008-07-24 |
| WO2008065068A2 (en) | 2008-06-05 |
| AU2007327621A1 (en) | 2008-06-05 |
| JP2010510974A (ja) | 2010-04-08 |
| EP2097386A2 (en) | 2009-09-09 |
| CN101541759A (zh) | 2009-09-23 |
| CA2670105A1 (en) | 2008-06-05 |
| MX2009005622A (es) | 2009-06-12 |
| US20100075966A1 (en) | 2010-03-25 |
| KR20090083408A (ko) | 2009-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0718182A2 (pt) | Oligorribonucleotídeos e seus usos. | |
| BRPI0814267A2 (pt) | Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico. | |
| BRPI0808098A2 (pt) | 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas e seu uso | |
| BRPI0821276A2 (pt) | Produto, e, uso do produto | |
| BRPI0814963A2 (pt) | Pró-fármacos de dipeptóides e seu uso | |
| FI20045030L (fi) | Proomusovitelma, proomuyksikkö ja hinausyksikkö | |
| BRPI0813263A2 (pt) | Oxazolidinonas substituídas e seu uso | |
| EP2079489A4 (en) | ABSORBENT ARTICLE WITH ABSORPTION STRUCTURE | |
| SI2548577T1 (sl) | Človeška protitelesa proti il-23, sestavki, postopki in uporabe | |
| BRPI0720124A2 (pt) | Composições farmacêuticas e seus métodos de uso. | |
| BRPI0821027A2 (pt) | 4-(4-ciano-2-tioaril) dihidropirimidinonas e seu uso | |
| BRPI0718192A2 (pt) | Corantes dispersos, sua preparação e seu uso. | |
| BRPI0816372A2 (pt) | Ácidos 6-fenilnicotínicos substituídos e seu uso | |
| BRPI0817542A2 (pt) | NOVOS INIBIDORES DE sEH E SEU USO | |
| BRPI0817974A2 (pt) | Combinações de substâncias ativas com propriedades inseticidas e acaricidas. | |
| BRPI0810475A2 (pt) | uso de dimiracetam no tratamento de dor crônica | |
| BRPI0813453A2 (pt) | 3-ciclopropil-4-(3-tiobenzoil)pirazol e seu uso como herbicida. | |
| BRPI0810461A2 (pt) | Combinação de drogas e seu uso no tratamento de perda muscular | |
| SI1858481T1 (sl) | Oftalmološki sestavki in njihova uporaba | |
| BRPI0921225A2 (pt) | caixinha porta-remédio e seu uso. | |
| BRPI0909096A2 (pt) | uso de conjugados de interleicna-1 no tratamento de diabetes | |
| BRPI0812340A2 (pt) | Macrociclos e seus usos | |
| EP1889424A4 (en) | MESSAGE TRANSMISSION IN PAGE MODE | |
| FI20060864A0 (fi) | Integroitu systeemi, laite ja niiden käyttö | |
| FI20061043L (fi) | Selän hoitolaite |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |